Dr. Sushil Kotru
Associate Director & Head - Diabetes & Metabolic Diseases
Endocrinology & Diabetes
Max Super Speciality Hospital, Bathinda
Experience: 15+ Years
Share Doctor Profile
Select Hospital
About Dr. Sushil Kotru
- Honorary Visiting Faculty & Professor, Adesh Institute of Medical Sciences & Research, Adesh University, Barnala Road, Bathinda, Punjab (May'2020 - Till Date)
- Associate Director & Head, Diabetes & Endocrinology Department, MAX Super Speciality Hospital, Bathinda, Punjab (April'2013 - Till Date)
- Assistant Professor & Head , Diabetes & Obesity Care Unit, Department of Medicine, Adesh Institute of Medical Sciences & Research, Adesh University, Barnala Road, Bathinda, Punjab (Oct'2009 - Mar'2013)
- Head, Bee Enn Diabetes & Obesity Care Centre, Jammu (Nov'2008 - Sept'2009)
- Medical Director & Chief Consultant Physician & Diabetologist - DNK Hospital, Jodhpur (Dec'2006 - Oct'2008)
- Worked at Escorts Goyal Heart Centre, Jodhpur In Super Speciality Cardiac Care Unit as Senior Registrar (Oct'2005-Nov'2006)
- Worked as Chief Physician at SHH Balotra Raj (Dec'2003-Jul'2005)
- Pursuing fellowship in Endocrinology from the University of South Wales, UK
- Fellowship in diabetes from CMC Vellore
- Advanced Certificate course in Diabetics from Cleveland Clinic, USA (August 2008)
- Practical Diabetology Course from Steno Diabetes Centre Denmark
- Postgraduate certificate course in clinical Diabetology from IMA, New Delhi (April 2006)
- MD from Dr S.N. Medical College, Jodhpur (July 2003)
- MBBS from JLN Medical College, Ajmer (January 2000)
- FELLOWSHIP IN DIABETIC FOOT MANAGEMENT, INDIAN PODIATRY ASSOCIATION (2021).
- MASTERS IN ENDOCRINOLOGY, UNIVERSITY OF SOUTH WALES, UK (ENROLMENT NO. 12066796) (2018)
- POSTGRADUATE DIPLOMA IN ENDOCRINOLOGY, UNIVERSITY OF SOUTH WALES, UK (ENROLMENT NO. 12066796) WITH DISTINCTION (2015)
- FELLOWSHIP IN DIABETES MANAGEMENT (DFID) FROM CMC VELLORE
- CASE-BASED LEARNING PROGRAMME ON SLEEP DISORDERS BY ACE SCHOOL OF SLEEP MEDICINE.
- DIABETES CARE CURRICULUM FOR INDIAN PHYSICIANS, JOSLIN DIABETES CENTER (AFFILIATION WITH HARVARD MEDICAL SCHOOL)
- PRACTICAL GUIDANCE IN COMPREHENSIVE DIABETES MANAGEMENT, FROM TOTAL INSTITUTE OF HEALTH EDUCATION, INDORE.
- POST GRADUATE CERTIFICATE COURSE IN CLINICAL DIABETOLOGY, IMA AKN SINHA INSTITUTE, NEW DELHI
- WORKSHOP & TRAINING IN PC BASED VASCULAR DOPPLER VERSALAB, VIBROTHERM & PODIASCAN FOR DIABETES FOOT ANALYSIS FROM DIABETES FOOT CARE INDIA
- DISTANCE-BASED EARNING PROGRAMME ON MANAGEMENT OF TYPE 2 DIABETES FROM ROYAL COLLEGE ACCREDITED COURSE SERIES, UK.
- THE STENO COURSE ON PRACTICAL DIABETOLOGY HELD BY STENO DIABETES EDUCATION CENTER, DENMARK
- ADVANCED CERTIFICATE COURSE IN DIABETES- 2014, CLEVELAND CLINIC.
- ADVANCED COURSE IN HYPERTENSION FROM ROYAL COLLEGE ACCREDITED COURSE SERIES
- POSTGRADUATION [MD-MEDICINE] FROM DR.S.N. MEDICAL COLLEGE, JODHPUR, UNIVERSITY OF RAJASTHAN, RECOGNIZED BY MEDICAL COUNCIL OF INDIA (MCI) - 1ST ATTEMPT (2000-2003)
- GRADUATION [MBBS+INTERNSHIP] FROM JLN MEDICAL COLLEGE, AJMER, UNIVERSITY OF RAJASTHAN, RECOGNIZED BY MEDICAL COUNCIL OF INDIA (MCI)-1ST ATTEMPT (1993-1999)
- PRESIDENT “C-DOT FORUM” BATHINDA
- EX-SECRETARY PHYSICIAN FORUM, BATHINDA
- INDIAN MEDICAL ASSOCIATION( RAJ/6754/54/10/111441/2004-05/CL)
- AMERICAN DIABETES ASSOCIATION( Membership no- 080430810039967) since Feb 2008
- LIFE MEMBER OF API( L-14359)
- EASD ( MEMBERSHIP NUMBER- 281331)
- INDIAN THYROID SOCIETY ( MEMBERSHIP NUMBER- 1354)
- MEMBER AACE( 2014-2015)
- MEMBER INDIAN ASSOCIATION OF SEXOLOGY( IAS-1405)
- MEMBER OF MEDICAL & SCIENTIFIC ETHICS COMMITTEE
- CHAIRED A SESSION AT “GASTROENTEROLOGY CONCLAVE 2011” AT ADESH INSTITUTE OF MEDICAL SCIENCES AND RESEARCH, BATHINDA.
- HONOURED WITH BEST POSTER PRESENTATION AWARD DURING 13TH ANNUAL DFSI CONFERENCE HELD AT CHANDIGARH, 2015.
- DELIVERED A LECTURE ON “EMPAREG OUTCOME STUDY ON SGLT2 INHIBITORS” AT HP APICON 2016, IGMC SHIMLA.
- AWARDED HERO OF THE YEAR AWARD BY MAX HEALTHCARE, 2015-16.
- RECEIVED DIABETES AWARENESS INITIATIVE AWARD FROM WORLD DIABETES CONGRESS ON 23RD FEB 2017 AT NEW DELHI FOR SPREADING DIABETES AWARENESS IN FOUR STATES PUNJAB, J&K, RAJASTHAN AND HARYANA.
- CHAIRED TWO SESSIONS AT NATIONAL CONFERENCE ON DIABETES AND ENDOCRINOLOGY (SPEEDCON 2019), AT LEELA AMBIENCE, GURUGRAM, NEW DELHI.
- DELIVERED A LECTURE ON “DECLARE TIMI- STUDY ON SGLT2 INHIBITORS” AT HP APICON 2019, IGMC SHIMLA.
- AWARDED “RSSDI-USV AWARD FOR EXCELLENCE IN DIABETES CARE 2019” AT 47TH ANNUAL MEETING OF RSSDI 2019, JAIPUR.
- CHAIRED TWO SESSIONS AT NATIONAL CONFERENCE ON DIABETES AND ENDOCRINOLOGY (SPEEDCON 2020), AT LEELA AMBIENCE, GURUGRAM, NEW DELHI.
- PANELIST FOR NATIONAL LEVEL MEETING ON “DIABETES AND COVID-19 PANDEMIC” (06.05.2020)
- PANELIST FOR ‘LAUNCH MEET’ OF ‘NOVEL PATENTED BREAK THROUGH ANTIBIOTIC-EMROK FOR DIABETIC FOOT INFECTIONS’ FROM WOCKHARDT ON JULY,23’2020.
- PANELIST ON NDTV 24*7 FOR LIVE DISCUSSION ON COVID-19 PANDEMIC.
- SPEAKER FOR e-CME ON “MANAGEMENT OF HYPOGLYCEMIA IN HOSPITALISED PATIENTS” ON 6-6-2020 BY TORRENT PHARMA.
- DELIVERED LECTURE TO FACULTY & STUDENTS OF ‘BABA FARID UNIVERSITY’ ON “HEALTHY LIVING DURING COVID-19 PANDEMIC & LOCKDOWN”
- PANELIST IN NATIONAL LEVEL MEETING ON “SCOPE & RELEVANCE OF SGLT2i/DPP4i FDC TO IMPACT PATIENT TREATMENT OUTCOME” HELD BY ‘BOEHRINGER INGELHEIM’.
- ON ADVISORY BOARD PANEL FOR ‘SANOFI’, ‘BOEHRINGER INGELHEIM’, ‘ASTRAZENECA’, ‘MSD’, ‘WOCKHARDT’, ‘USV’, ‘JOHNSON & JOHNSON’, ‘GLENMARK’.
- LIVE RADIOTALK ON “COVID-19 & DIABETES” ON ALL INDIA RADIO.
- PROGRAMME ON “COVID-19 & COMORBIDITIES” ON DOORDARSHAN J&K FOR PUBLIC AWARENESS.
- SO MANY FACEBOOK ACTIVITIES FOR PUBLIC AWARENESS ABOUT DIABETES & OTHER HORMONAL DISORDERS.
- RUNNING YOUTUBE CHANNEL FOR PUBLIC AWARENESS ABOUT DIABETES, OTHER DISORDERS & HEALTHY LIFESTYLE.
- SPEAKER FOR THE TOPIC “OPTIMAL GLYCEMIC CONTROL: EVOLVING ROLE OF FAST-ACTING INSULIN ASPART” ON 29-09-2019 BY NOVO NORDISK.
- Endocrinology & Diabetes
- A review entitled “Role of mRNAs in Diabetic Neuropathy: mechanisms and possible interventions” has been communicated.
- A review entitled “Role of mRNAs in the pathogenesis of T2DM, Insulin secretion, Insulin resistance and β-cell dysfunction: The story so far” has been accepted and published by Journal of Physiology and Biochemistry.
- Principal investigator in “Assessment of Hypogonadism in men with Type 2 DM- A cross-sectional study”.
- Purohit, A., Joshi, K., Kotru, B. and Kotru, S. (2012) : Hypolipidemic effects of Bees wax on serum lipid parameters in induced hyperlipidemic male albino Rabbits. J. of cell & tissue research., 12(3): 3311-3316.
- Purohit, A., Joshi, K., Kotru, B. and Kotru, S. (2013) : Effect of Indian propolis on haematological parameters in experimentally induced hyperlipidemic male albino Rabbits. Asian J. of Pharmaceutical & clinical Research., 6 (1) : 17-19.
- Purohit, A., Joshi, K., Kotru, B., Kotru, S. and Heera Ram (2012) : Histological study of antiatherosclerotic effect of propolis in induced hypercholesterolemic male albino rabbits. Indian J. of fundamental & applied life sciences., 2 (2) : 384-390.
- Purohit, A., Kotru, B., Joshi, K., and Kotru, S. (2015) : Toxicological Study Of Policosanol In Experimentally Induced Hyperlipidemic Male Albino Rabbits. International Journal of Pharmacology and Toxicology., 5(1) : 38-41.
- Joshi, K., Kotru, B. and Kotru, S. (2015): Haematological Study Of Indian Bees Wax in Experimentally Induced Hyperlipidemic Male Albino Rabbits. International Journal Of Pharmaceutical Sciences And Research. 5(1) : 10-14.
- Kotru et. Al( 2014): Intervention of Diabetes foot care practices on the prevention of new diabetic foot ulcers in patients with type 2 Diabetes Mellitus, Accepted 22 November, 2014, Journal name J. Diabetes Metab. 6:494.
- Investigator in LANDMARC Study (Longitudinal Nationwide Study on Management and Real-World Outcomes of Diabetes in India), conducted by Sanofi Longitudinal Nationwide study on Management And Real-world outcomes of diabetes in India (LANDMARC study) aimed to understand the micro- and macrovascular complications, glycemic control, and time to treatment adaptation in Indian subjects with T2DM over a follow-up period of 3 years. LANDMARC (CTRI/2017/05/008452) is the first pan-India, prospective, multicenter, observational, and longitudinal study of subjects with T2DM.
- Investigator in IDMPS Study (International Diabetes Management Practices Study), conducted by Sanofi group.
- Co-Investigator in a study “Pharmacogenetics of SGLT2 inhibitors”, conducted by Central University of Punjab.
OPD Timings
Max Super Speciality Hospital, Bathinda
Monday To Friday- 09:30 AM TO 4:00 PM (With Prior appointment)